Cm Management, LLC Cognition Therapeutics Inc Transaction History
Cm Management, LLC
- $91.4 Million
- Q1 2025
A detailed history of Cm Management, LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Cm Management, LLC holds 400,000 shares of CGTX stock, worth $128,000. This represents 0.18% of its overall portfolio holdings.
Number of Shares
400,000
Previous 200,000
100.0%
Holding current value
$128,000
Previous $150,000
12.0%
% of portfolio
0.18%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
14MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.92 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$705,7200.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$396,5330.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.01MShares$322,4270.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$194,6840.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $7.27M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...